UPDATED: FDA Approval: Nevro Corp. $126M IPO with No FDA Approved Product: Case Study
UPDATED in the middle July 1, 2015 Nevro Appoints Lisa Earnhardt of Intersect ENT to its Board of Directors UPDATED: May 11, 2015 below November 10, 2014 Board Whores Edition I Back pain device maker Nevro jumps after $126M IPO tops targets Nevro, a startup waiting for approval of a device...